Medicamen Organics Reports 49 Percent Total Revenue Increase In H1 FY25
New Delhi [India], November 19: Medicamen Organics Limited (MOL) (NSE- MEDIORG) one of the prominent players in the pharmaceutical sector specializing in the development, manufacturing, and distribution of an extensive range of pharmaceutical dosages has announced its Unaudited H1 FY25 results Key Financial Highlights H1 FY25 • Total Revenue of ₹ 1,685.66 Lakhs, YoY growth of 48.91% • EBITDA of ₹ 277.44 Lakhs, […]
Continue Reading